Efalizumab in the Treatment of Alopecia, Phase II
This study has been withdrawn prior to enrollment.
(Newly identified safety concerns have changed the risk and benefit considerations)
Information provided by:
First received: September 2, 2008
Last updated: March 31, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||July 2009|
|Estimated Primary Completion Date:||July 2009 (Final data collection date for primary outcome measure)|